Two Sigma Securities, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $1.61 Million - $1.77 Million	3,500 Added 71.43%	8,400 $3.91 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $274,967 - $339,871	700 Added 16.67%	4,900 $2.3 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $203,845 - $223,040	500 Added 13.51%	4,200 $1.76 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $720,300 - $862,428	-2,100 Reduced 36.21%	3,700 $1.51 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $608,724 - $652,428	-1,800 Reduced 23.68%	5,800 $2.02 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $660,282 - $739,011	2,100 Added 38.18%	7,600 $2.67 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $254,907 - $290,790	900 Added 19.57%	5,500 $1.73 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1 Million - $1.13 Million	3,500 Added 318.18%	4,600 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $301,213 - $336,082	1,100 New	1,100 $318,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $952,246 - $1.27 Million	4,600 Added 230.0%	6,600 $1.56 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $715,820 - $848,680	-2,800 Reduced 58.33%	2,000 $544,000
Q2 2020 Sep 10, 2020	BUY	$225.48 - $295.8 $180,384 - $236,640	800 Added 20.0%	4,800 $1.39 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $2.88 Million - $3.57 Million	-14,400 Reduced 78.26%	4,000 $952,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $3.07 Million - $4.12 Million	18,400 New	18,400 $4.03 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $781,281 - $879,323	-4,700 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $148,149 - $171,333	-900 Reduced 16.07%	4,700 $862,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $1.13 Million - $1.34 Million	-6,900 Reduced 55.2%	5,600 $1.03 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $3.16 Million - $4 Million	-20,800 Reduced 62.46%	12,500 $2.07 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $268,368 - $308,384	1,600 Added 5.05%	33,300 $6.42 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $1.63 Million - $1.9 Million	-11,200 Reduced 26.11%	31,700 $5.39 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $6.5 Million - $7.6 Million	42,900 New	42,900 $6.99 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.9 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.45 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.82 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.67 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account